Evaluation of pharmacokinetics, safety, and efficacy of [²¹¹At] meta-astatobenzylguanidine ([²¹¹At] MABG) in patients with pheochromocytoma or paraganglioma (PPGL): A study protocol

• Masao Kobayakawa ,

  Roles Conceptualization, Funding acquisition, Investigation, Methodology, Project administration, Writing – original draft

  * E-mail: mkobaya@fmu.ac.jp

  Affiliation Medical Research Center, Fukushima Medical University, Fukushima, Japan

  https://orcid.org/0000-0002-5532-7364

  ⨯
• Tohru Shiga,

  Roles Conceptualization, Data curation, Investigation, Methodology

  Affiliation Advanced Research Center, Fukushima Global Medical Science Center, Fukushima Medical University, Fukushima, Japan

  ⨯
• Kazuhiro Takahashi,

  Roles Investigation, Methodology

  Affiliation Advanced Research Center, Fukushima Global Medical Science Center, Fukushima Medical University, Fukushima, Japan

  ⨯
• Shigeyasu Sugawara,

  Roles Data curation, Investigation

  Affiliation Advanced Research Center, Fukushima Global Medical Science Center, Fukushima Medical University, Fukushima, Japan

  ⨯
• Kaori Nomura,

  Roles Methodology, Writing – review & editing

  Affiliation Advanced Research Center, Fukushima Global Medical Science Center, Fukushima Medical University, Fukushima, Japan

  https://orcid.org/0000-0003-4386-3458

  ⨯
• Kazuhiko Hanada,

  Roles Investigation, Methodology

  Affiliation Department of Pharmacometrics and Pharmacokinetics, Meiji Pharmaceutical University, Kiyose, Tokyo, Japan

  ⨯
• Naoki Ishizuka,

  Roles Methodology, Supervision

  Affiliation Center for Digital Transformation of health, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Hiroshi Ito

  Roles Supervision

  Affiliation Advanced Research Center, Fukushima Global Medical Science Center, Fukushima Medical University, Fukushima, Japan

  ⨯